维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Kallinteris"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	CD4 T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines 显示文摘	Xu M Kallinteris N L yon Hofe E	2012	Vaccine2012，30，18：	1
2	li-Key/MHCclass 11 epitope peptides as helper T cell vaccines for cancer and infectious disease显示文摘	Kallinteris N L Powell D Blackwell C E		0，，01：	1
3	Novel Functionalized Biodegradable Polymers for Nanoparticle Drag Delivery Systems 显示文摘	Kallinteri P Higgins S Hutcheon G A et a l	2005	Biomacromolecules2005，6，4：	1
4	Arsenic trioxide lipo- somes: encapsulation efficiency and in vitro stability 显示文摘	Kallinteri P Fatouros D Klepetsanis P	2004	J Liposome Res2004，14，12：	1
5	Efficacy of nisin and/or natamycin to improve the shelf-life of Galotyri cheese显示文摘	Kallinteri L D Kostoula O K Savvaidis I N	2013	Food Microbiology2013，36，2：	1
6	Efficacy of Nisin and/or Natamycin to Improve the Shelf-Life of Galo-tyri Cheese 显示文摘	KALLINTERI L D KOSTOULA O K SAVVAIDIS I N	2013	Food Microbiology2013，36，：	1
7	A new era in anticancer peptide vaccines 显示文摘	Perez SA von Hofe E Kallinteris NL	2010	Cancer2010，116，9：	1
8	CD4+T-cell activation for immunotherapy of malignancies using Ii-Key/MHC classⅡepitope hybrid vaccines显示文摘	Xu M Z Kallinteris N L Von H E	2012	Vaccine2012，30，18：	1
9	Ii-Key/HER-2/neu MHC class-Ⅱantigenic epitope vaccine peptide for breast cancer显示文摘	Gillogly M E Kallinteris N L Xu M	2004	Cancer Immunol Immunother2004，53，6：	1
10	Results from a pha- se I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer显示文摘	Perez S A Kallinteris N L Bisias S	2010	Clinical Cancer Research2010，16，13：	1
11	Enhanced CD4+T-cell response in DR4-transgenic mice to a hybrid peptide linking the Ii-Key segment of the invariant chain to the melanoma gp100(48-58)MHC classⅡepitope显示文摘	Kallinteris N L Wu S Lu X	2005	J Immunother2005，28，4：	1
12	li-Key/ HER-2/neu (776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors显示文摘	Sotiriadou NN Kallinteris NL Gritzapis AD	2007	Cancer Im- munol Immunother2007，56，5：	1
13	Enhanced CD4+ T-cell response in DR4-transgenic mice to a hybrid peptide linking the Ii-Key segment of the invariant chain to the melanoma gplO0 (48-58) MHC class 11 epitope 显示文摘	Kallinteris N L Ku S Z Lu X Q	2005	J Immunother2005，28，4：	1
14	Ii-Key/HER-2/neu MHC class-Ⅱ antigenic epitope vaccine peptide for breast cancer 显示文摘	Gillogly M E Kallinteris N L Xu M	2004	Cancer Immunol Immunother2004，53，6：	1
15	Tmnor immunothempy by convertin- g tumor cells to MHC class II-positive, Ii protein-negative phenotype Cancer Immtmol 显示文摘	Lu X Kallinteris NL Li J	2003	Immunother2003，52，10：	1
16	Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: Effect of lipid composition显示文摘	Maria Kokkona Paraskevi Kallinteri Dimitrios Fatouros	2000	European Journal of Pharmaceutical Sciences2000，9，3：	1
17	Arsenic trioxide liposomes:encapsulation efficiency and in vitro stability显示文摘	Kallinteri P Fatouros D Klepetsanis P	2004	J Liposome Res2004，14，：	1
18	CD4^+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class Ⅱ epitope hybrid vaccines显示文摘	Xu M Kallinteris N L yon Hofe E	2012	Vaccine2012，30，18：	1
19	Results from a phase I clinical study of the novel Ii-Key/HER-2/ neu(776-790) hybrid peptide vaccine in patients with prostate cancer显示文摘	Perez S A Kallinteris N L Bisias S	2010	Clin Cancer Res2010，16，13：	1
20	Nanomedieines and nanotoxicology: some physiological principles显示文摘	Garnett MC Kallinteri P	2006	Occup Med (Lond)2006，56，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示